137 related articles for article (PubMed ID: 23679566)
1. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
Gold DV; Stein R; Burton J; Goldenberg DM
Int J Clin Exp Pathol; 2010 Nov; 4(1):1-12. PubMed ID: 21228923
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
4. Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.
Duex JE; Owens C; Chauca-Diaz A; Dancik GM; Vanderlinden LA; Ghosh D; Leivo MZ; Hansel DE; Theodorescu D
Cancer Res; 2017 Sep; 77(18):4858-4867. PubMed ID: 28674079
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
Xi T; Zhang G
PLoS One; 2018; 13(3):e0193427. PubMed ID: 29596435
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD24 as a novel immunotherapy for solid cancers.
Yang Y; Zhu G; Yang L; Yang Y
Cell Commun Signal; 2023 Nov; 21(1):312. PubMed ID: 37919766
[TBL] [Abstract][Full Text] [Related]
7. Quantification of pancreatic cancer proteome and phosphorylome: indicates molecular events likely contributing to cancer and activity of drug targets.
Britton D; Zen Y; Quaglia A; Selzer S; Mitra V; Löβner C; Jung S; Böhm G; Schmid P; Prefot P; Hoehle C; Koncarevic S; Gee J; Nicholson R; Ward M; Castellano L; Stebbing J; Zucht HD; Sarker D; Heaton N; Pike I
PLoS One; 2014; 9(3):e90948. PubMed ID: 24670416
[TBL] [Abstract][Full Text] [Related]
8. Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.
Klee EW; Bondar OP; Goodmanson MK; Dyer RB; Erdogan S; Bergstralh EJ; Bergen HR; Sebo TJ; Klee GG
Clin Chem; 2012 Mar; 58(3):599-609. PubMed ID: 22247499
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer.
Heller A; Zörnig I; Müller T; Giorgadze K; Frei C; Giese T; Bergmann F; Schmidt J; Werner J; Buchler MW; Jaeger D; Giese NA
Cancer Immunol Immunother; 2010 Sep; 59(9):1389-400. PubMed ID: 20514540
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer.
Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Friedrich AW; Karch H; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinić J; Müthing J
PLoS One; 2009 Aug; 4(8):e6813. PubMed ID: 19714252
[TBL] [Abstract][Full Text] [Related]
11. Proteome Profiling of 1 to 5 Spiked Circulating Tumor Cells Isolated from Whole Blood Using Immunodensity Enrichment, Laser Capture Microdissection, Nanodroplet Sample Processing, and Ultrasensitive nanoLC-MS.
Zhu Y; Podolak J; Zhao R; Shukla AK; Moore RJ; Thomas GV; Kelly RT
Anal Chem; 2018 Oct; 90(20):11756-11759. PubMed ID: 30269481
[TBL] [Abstract][Full Text] [Related]
12. Checkpoint CD24 function on tumor and immunotherapy.
Huang S; Zhang X; Wei Y; Xiao Y
Front Immunol; 2024; 15():1367959. PubMed ID: 38487533
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.
Wang S; Zheng Y; Yang F; Zhu L; Zhu XQ; Wang ZF; Wu XL; Zhou CH; Yan JY; Hu BY; Kong B; Fu DL; Bruns C; Zhao Y; Qin LX; Dong QZ
Signal Transduct Target Ther; 2021 Jul; 6(1):249. PubMed ID: 34219130
[TBL] [Abstract][Full Text] [Related]
14. Assessment of spatial transcriptomics for oncology discovery.
Lyubetskaya A; Rabe B; Fisher A; Lewin A; Neuhaus I; Brett C; Brett T; Pereira E; Golhar R; Kebede S; Font-Tello A; Mosure K; Van Wittenberghe N; Mavrakis KJ; MacIsaac K; Chen BJ; Drokhlyansky E
Cell Rep Methods; 2022 Nov; 2(11):100340. PubMed ID: 36452860
[TBL] [Abstract][Full Text] [Related]
15. Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting.
Liu W; Xie L; He YH; Wu ZY; Liu LX; Bai XF; Deng DX; Xu XE; Liao LD; Lin W; Heng JH; Xu X; Peng L; Huang QF; Li CY; Zhang ZD; Wang W; Zhang GR; Gao X; Wang SH; Li CQ; Xu LY; Liu W; Li EM
Nat Commun; 2021 Aug; 12(1):4961. PubMed ID: 34400640
[TBL] [Abstract][Full Text] [Related]
16. Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer.
Yang R; Liu X; Thakolwiboon S; Zhu J; Pei X; An M; Tan Z; Lubman DM
J Proteomics Bioinform; 2016 Oct; 9(10):238-247. PubMed ID: 28503055
[TBL] [Abstract][Full Text] [Related]
17. CD24 in Head and Neck Malignancies-An Uprising Biomarker?
Carmel Neiderman NN; Shapira S; Klein L; Rafael D; Gorelik G; Kampel L; Arber N; Muhanna N
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138858
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma.
Yao L; Wang JT; Jayasinghe RG; O'Neal J; Tsai CF; Rettig MP; Song Y; Liu R; Zhao Y; Ibrahim OM; Fiala MA; Fortier JM; Chen S; Gehrs L; Rodrigues FM; Wendl MC; Kohnen D; Shinkle A; Cao S; Foltz SM; Zhou DC; Storrs E; Wyczalkowski MA; Mani S; Goldsmith SR; Zhu Y; Hamilton M; Liu T; Chen F; Vij R; Ding L; DiPersio JF
Cancer Res; 2023 Apr; 83(8):1214-1233. PubMed ID: 36779841
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach.
Baldelli E; Mandarano M; Bellezza G; Petricoin EF; Pierobon M
Cell Rep Methods; 2022 Aug; 2(8):100271. PubMed ID: 36046628
[TBL] [Abstract][Full Text] [Related]
20. Surprising magic of CD24 beyond cancer.
Wang H; Shi P; Shi X; Lv Y; Xie H; Zhao H
Front Immunol; 2023; 14():1334922. PubMed ID: 38313430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
